Literature DB >> 8672519

Pulmonary allograft ischemic time: an important predictor of survival after lung transplantation.

G I Snell1, M Rabinov, A Griffiths, T Williams, A Ugoni, R Salamonsson, D Esmore.   

Abstract

BACKGROUND: Traditionally organ availability in human lung transplantation has been limited by aiming to keep the graft ischemic time under 6 hours. To maximize organ supply in a country with a widely spread population, we have routinely procured organs beyond this time. Our experience outlines the clinical consequences of a prolonged allograft ischemic time.
METHODS: Between 1990 and 1994 we performed 106 lung or heart-lung transplantations. The average graft ischemic time was 323 +/- 93 minutes. Lung preservation included a prostacyclin infusion (40 to 80 ng/kg/min for 10 minutes) and cold modified Euro-Collins solution flush. Organs were stored and transported on ice at 6 degrees to 10 degrees C. Graft ischemic time, transplant type, age, gender, cytomegalovirus status, and anesthetic time were subject to multivariate Cox regression analysis.
RESULTS: Survival and graft ischemic times for heart-lung (n = 38), single lung (n = 33), and bilateral lung transplantation (n = 35) were not significantly different. Graft ischemic time was an independent predictor of survival (p < 0.01). Subgroup analysis notes the effect to be most pronounced beyond 5 hours (p = 0.02, hazard ratio 3.44, confidence interval 1.12 to 9.8).
CONCLUSIONS: Pulmonary allograft ischemic time beyond 5 hours does not result in acceptable outcomes although survival is reduced. Attempts should be made to minimize graft ischemic times with careful coordination of transport and personnel.

Entities:  

Mesh:

Year:  1996        PMID: 8672519

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  14 in total

1.  Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality.

Authors:  D Hayes; M G Hartwig; J D Tobias; D Tumin
Journal:  Am J Transplant       Date:  2016-07-13       Impact factor: 8.086

2.  Geographic distance between donor and recipient does not influence outcomes after lung transplantation.

Authors:  Sara A Hennessy; Tjasa Hranjec; Abbas Emaminia; Damien J Lapar; Benjamin D Kozower; Irving L Kron; David R Jones; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2011-10-31       Impact factor: 4.330

3.  Lung transplantation: a decade of experience.

Authors:  B F Meyers; J Lynch; E P Trulock; T J Guthrie; J D Cooper; G A Patterson
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

Review 4.  Shear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation.

Authors:  Shampa Chatterjee; Gary F Nieman; Jason D Christie; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-19       Impact factor: 5.464

5.  Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era.

Authors:  Abbas Emaminia; Sara A Hennessy; Tjasa Hranjec; Damien J LaPar; Benjamin D Kozower; David R Jones; Irving L Kron; Christine L Lau
Journal:  J Thorac Cardiovasc Surg       Date:  2011-02-12       Impact factor: 5.209

6.  Targeted endothelial delivery of nanosized catalase immunoconjugates protects lung grafts donated after cardiac death.

Authors:  Gerhard Preissler; Florian Loehe; Ines V Huff; Ulrich Ebersberger; Vladimir V Shuvaev; Iris Bittmann; Iris Hermanns; James C Kirkpatrick; Karl Fischer; Martin E Eichhorn; Hauke Winter; Karl W Jauch; Steven M Albelda; Vladimir R Muzykantov; Rainer Wiewrodt
Journal:  Transplantation       Date:  2011-08-27       Impact factor: 4.939

7.  Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs.

Authors:  Raphael Briot; James A Frank; Tokujiro Uchida; Jae W Lee; Carolyn S Calfee; Michael A Matthay
Journal:  Chest       Date:  2008-11-18       Impact factor: 9.410

8.  Risk factors for reperfusion injury after lung transplantation.

Authors:  Silvia R Cottini; Nicolas Lerch; Marc de Perrot; Miriam M Treggiari; Anastase Spiliopoulos; Laurent Nicod; Bara Ricou
Journal:  Intensive Care Med       Date:  2006-03-07       Impact factor: 17.440

9.  Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function.

Authors:  Daniel P Mulloy; Matthew L Stone; Ivan K Crosby; Damien J Lapar; Ashish K Sharma; David V Webb; Christine L Lau; Victor E Laubach; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-31       Impact factor: 5.209

10.  Lung transplantation using allografts with more than 8 hours of ischemic time: A single-institution experience.

Authors:  Samantha E Halpern; Sandra Au; Samuel J Kesseli; Madison K Krischak; Danae G Olaso; Brandi A Bottiger; John C Haney; Jacob A Klapper; Matthew G Hartwig
Journal:  J Heart Lung Transplant       Date:  2021-06-23       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.